Yahoo MoviesVictor Oladipo with a buzzer beater vs the Washington Wizards
Victor Oladipo (Houston Rockets) with a buzzer beater vs the Washington Wizards, 01/26/2021
Victor Oladipo (Houston Rockets) with a buzzer beater vs the Washington Wizards, 01/26/2021
New York, New York--(Newsfile Corp. - March 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Multiplan Corporation F/K/A Churchill Capital Corp. Iii (NYSE: MPLN) alleging that the Company violated federal securities laws.Class Period: July 12, 2020 and November 10, 2020Lead Plaintiff Deadline: April 26, 2021Learn more about your recoverable losses in MPLN:http://www.kleinstocklaw.com/pslra-1/multiplan-corporation-f-k-a-churchill-capital-corp-iii-loss-submission-form?id=13455&from=5The filed complaint alleges that Multiplan Corporation F/K/A Churchill Capital ...
New York, New York--(Newsfile Corp. - March 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that the Company violated federal securities laws.Class Period: August 3, 2020 and December 15, 2020Lead Plaintiff Deadline: March 16, 2021Learn more about your recoverable losses in PEN:http://www.kleinstocklaw.com/pslra-1/penumbra-inc-loss-submission-form?id=13456&from=5The filed complaint alleges that Penumbra, Inc. made materially false and/or misleading statements and/or failed ...
Radnor, Pennsylvania--(Newsfile Corp. - March 8, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against iRhythm Technologies, Inc. (NASDAQ: IRTC) ("iRhythm") on behalf of those who purchased or acquired iRhythm common stock between August 4, 2020 and January 28, 2021, inclusive (the "Class Period").Investor Deadline Alert: Investors who purchased or acquired iRhythm common stock during ...
SMU coach Travis Mays will not return next season after compiling a 58-50 record over five seasons. Athletic director Rick Hart said Monday night that he had decided not to renew Mays' contract. The Mustangs, whose last NCAA Tournament appearance was in 2008, lost all six games they played this season.
The new policy could give Biden a political boost in Florida, where Venezuelans spent years lobbying then-President Trump against deportation.
New York, New York--(Newsfile Corp. - March 8, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GTT Communications, Inc. (NYSE: GTT) between May 5, 2016 and November 9, 2020, inclusive (the "Class Period"), of the important March 15, 2021 lead plaintiff deadline in the securities class action first filed by the firm.SO WHAT: If you purchased GTT securities during the Class Period you may ...
Solidarity was the message at the 1000 Islands Gananoque Chamber of Commerce's second annual International Women's Day event Monday afternoon. The event, held over Zoom due to the COVID-19 pandemic, was a two-part affair featuring many prominent local women with dozens of attendees. The first half featured a keynote address by former federal minister Dr. Jane Philpott. Now the dean of the Faculty of Health Sciences at Queen's University’s School of Medicine, Philpott's address touched on multiple topics related to women in the health-care workforce. While gains are being made by women in the health-care field, with almost half of all doctors in Canada being women, Philpott said that is only part of the equation. "While women end up getting into the field, they often don't rise to the leadership positions," said Philpott. She referenced how there are 17 medical schools across the country, but only four deans are women. Philpott used most of her time to speak about the issues faced by minorities, particularly indigenous people, in Canada. "Now that we as women are seeing ourselves more and more represented in the workforce, and medicine in particular, there are other groups that we have started to recognize as not well represented," she said. Speaking on the systemic racism that is faced by minorities in the workforce, Philpott said under-representation is a main cause. An action table has been launched under Philpott at Queen's to deal with the problem. The Equity, Diversity and Inclusion action table has its own office in Health Sciences at Queen's that works toward greater representation both with staff and students. Bouncing off of a Queen's fund that is part of the action table, Philpott said that something people in the community could do to support people facing inequalities is a scholarship. Philpott is perhaps best known to many for having resigned from the role of President of the Treasury Board, over her opposition to the government's handling of the SNC-Lavalin affair, in early March 2019. She was later expelled from the Liberal caucus, along with former justice minister Jody Wilson-Raybould. Chamber executive director Amy Kirkland said at the event she was looking forward to speaking further with Philpott on fundraising for a possible scholarship. "Perhaps have a big event annually because I think it would be definitely in our interests to help," said Kirkland. Following Philpott's keynote, the afternoon moved to a forum made up of moderator and radio host Leanne Cater, and four women from Gananoque and the Township Leeds and the 1000 Islands. Panellists were Terri Dawson, owner of the Green Gecko; Wendy Merkley, owner of Andress Boat Works; Gananoque firefighter Dawn Kirkby and Lisa Robichaud, owner of Nature's Tonic. Some of the topics covered by the panellists were characteristics of success, the progression of women's rights and role models. Something they discussed was how they had all various people they looked up to who helped in their career and life path. "I have a melting pot of a lot of really great people I can look up to in my community and in my life," said Dawson. When asked about the importance of International Women's Day, Robichaud said that it is important to include boys in conversations that they normally would not have been a part of in the past. "It’s so important we talk about teaching our girls, but it's so important to teach our boys,” said Robichaud. "As women, we can hold each other up and support each other, but if we're not educating young boys on how to treat us as equals and love and have compassion, there's a disconnect.” Marshall Healey, Local Journalism Initiative Reporter, Brockville Recorder and Times
Oprah Winfrey's interview with Prince Harry and Duchess Meghan was big news on both sides of the Atlantic, with UK tabs the toughest on the couple.
New York, New York--(Newsfile Corp. - March 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of bluebird bio, Inc. (NASDAQ: BLUE) alleging that the Company violated federal securities laws.Class Period: May 11, 2020 and November 4, 2020Lead Plaintiff Deadline: April 13, 2021Learn more about your recoverable losses in BLUE:http://www.kleinstocklaw.com/pslra-1/bluebird-bio-inc-loss-submission-form?id=13454&from=5The filed complaint alleges that bluebird bio, Inc. made materially false and/or misleading statements ...
"Evie Jo is doing great with her sleeping and eating," Jinger (Duggar) Vuolo says in a new update
The S&P/TSX Composite Index just posted a fresh record high near 18,596 this morning. It could be the best time to make millions from the market if you invest in the right stocks at the right time. Here are two great Canadian tech stocks that just got cheap. The post TSX Rallies to Record High! Best Time to Make Millions From Stocks appeared first on The Motley Fool Canada.
The surge in BK Virus Infection cases spurs treatment opportunities, and many prominent players such as AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics, and others come forward to develop BK Virus Infection therapies.Los Angeles, USA , March 08, 2021 (GLOBE NEWSWIRE) -- BK Virus Infection Clinical Trials Review: An Update on Emerging Therapies and Treatment The surge in BK Virus Infection cases spurs treatment opportunities, and many prominent players such as AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics, and others come forward to develop BK Virus Infection therapies. DelveInsight’s “BK Virus (BKV) Infection Pipeline Insight'' report provides comprehensive insights about ...4+ companies and ...4+ pipeline drugs in the BK Virus Infection pipeline landscapes. It comprises BKV Infection pipeline drug profiles, including clinical and non-clinical stage products. It also includes the BK Virus Infection therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive BKV Infection pipeline products. Some of the crucial features of the BK Virus Infection Pipeline Report The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation, and EMA has offered PRIority MEdicines (PRIME) and Orphan Drug (ODD) designations to Viralym-M. The companies such as AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics, and many others are developing therapies to improve BK Virus Infection treatment scenario. BK Virus Infection pipeline assets such as ALVR-105, MAU868, SL-V10, HYB-BKV, and others are in different developmental stages to treat BKV Infection. The BK Virus Infection pipeline has HYB-BKV (Hybridize Therapeutics) in pre-clinical stage of development, while SL-V10 (SL VAXiGEN) and MAU868 (Amplyx Pharmaceuticals) in phase I and Phase II of clinical development respectively. Teriflunomide by Sanofi Genzyme is in the preclinical stage of development for the treatment of Human polyomavirus infections. Request for sample pages @ BK Virus Infection Clinical Trial Insight BK is a circular, double-stranded DNA virus from the polyomavirus family, including the JC virus and SV40. BK virus is one of 13 known polyomaviruses. Antibodies to BKV are available in around 80 to 90 percent of adults globally, indicating previous infection or exposure to the virus. Initial infection with BKV is mostly asymptomatic or associated with a mild flu-like illness. After primary infection, BK Virus Infection continues to be inactive or latent in the kidney and bladder. A weakened immune system may lead to BKV reactivation and cause severe disease. In patients who have had kidney transplants, BK Virus Infection can result in transplanted kidney loss. In the absence of effective treatment, decreasing immunosuppression is recommended; but, reducing the immunosuppression can result in acute organ rejection. BKV reactivation in the bladder can lead to hemorrhagic cystitis. Severe cases need bladder irrigation, clot evacuation, blood transfusion, stenting, and nephrostomy. There are presently no approved treatments for renal nephropathy or hemorrhagic cystitis caused by BK Virus Infection. The backbone of treatment for BK virus nephropathy is to lower the immunosuppression, as there is currently no particular antiviral for the BK virus. Clearance of BK viremia can be a sign of nephropathy resolution. BKV Pipeline Drugs Viralym-M by AlloVir ALVR 105 is a human leukocyte antigen (HLA) matched multi-virus-specific T cell candidate, also known as Viralym-M, developed by AlloVir. Viralym-M is designed to function an essential role in linking immunity between conditioning and reconstitution of their immune systems. Reinstituting immunity during this time of critical immune compromise, Viralym-M may substantially decrease or prohibit virus-associated morbidity and mortality and dramatically enhance patient results. Viralym-M has the potential to transform care for transplant patients fundamentally, as well as people who are at high risk for opportunistic viral infections by decreasing or preventing disease morbidity and dramatically improving. Research and Development Phase III NCT04390113: AlloVir commenced a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Viralym-M (ALVR105) for the treatment of patients with Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Cell Transplant (HCT) in January 2020. The study aims to assess Viralym-M, an allogeneic, off-the-shelf multi-virus-specific T cell therapy, which focuses on six viral pathogens: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. The study hypothesis is to administer Viralym-M to patients with virus-associated HC will show superiority for the time to resolution of HC as compared to patients when treated with placebo. The primary hypothesis will be evaluated in patients with BK virus viruria to show superiority over placebo in this population (BK Intent-to-Treat [ITT] population). A supplementary analysis will be carried out in all patients with any virus-associated HC (cytomegalovirus [CMV], human herpesvirus 6 [HHV-6], Epstein-Barr virus [EBV], JC virus [JCV], and/or adenovirus [AdV]) to assess the efficacy in this broader population (ITT Population). The study is anticipated to be finished by August 2022. For further product profiles, request @ BK Virus Infection Pipeline Landscape Scope of BKV Infection Pipeline Drug Insight Coverage: Global Major Players: 4+ Key Players Prominent Players: AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics, and many others. Key Drugs Profiles: 4+ Products Phases: BKV Infection Therapies Late-stage (Phase III) BK Virus Infection Therapies (Phase II) BKV Infection Therapies (Phase I) BK Virus Infection Therapies Pre-clinical stage and Discovery candidates Discontinued and Inactive candidates Targets: Protease Immune System Multiple Kinase Route of Administration: Intramuscular Intravenous Oral Subcutaneous Mechanism of Action: Immunostimulants Antisense oligonucleotides Antibody-dependent cell cytotoxicity; Immunomodulators Immunologic cytotoxicity; T lymphocyte replacements Molecule type: Monoclonal antibodies Stem Cell Therapy DNA Vaccines Product Type Monotherapy Combination Key Questions regarding Current BK Virus Infection Treatment Landscape and Emerging Therapies Answered in the Pipeline Report What are the current options for BK Virus Infection treatment? How many companies are developing therapies for the treatment of BK Virus Infection? How many are BK Virus Infection emerging therapies in the early-stage, mid-stage, and late stages of development to treat BK Virus Infection? What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and significant licensing activities that will impact the BK Virus Infection market? Which are the dormant and discontinued products and the reasons for the same? What is the unmet need for current therapies for the treatment of BK Virus Infection? What are the current novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing BK Virus Infection therapies? What are the key designations that have been granted for the emerging therapies for BK Virus Infection? How many patents are granted and pending for the emerging therapies for the treatment of BK Virus Infection? Table of Contents 1BK Virus Infection Report Introduction2BK Virus Infection Executive Summary3BK Virus Infection Overview4BK Virus Infection Analytical Perspective In-depth Commercial Assessment5BK Virus Infection Pipeline Therapeutics6BK Virus Infection Late Stage Products (Phase III)6.1ALVR-105: AlloVir7BK Virus Infection Mid Stage Products (Phase II)7.1MAU868: Amplyx Pharmaceuticals8BK Virus Infection Early Stage Products (Phase I)8.1SL-V10: SL VAXiGEN9BK Virus Infection Pre-clinical Products and Discovery Stage Products9.1HYB-BKV: Hybridize Therapeutics10BK Virus Infection Therapeutic Assessment11BK Virus Infection Inactive Products12Company-University Collaborations (Licensing/Partnering) Analysis13BK Virus Infection Key Companies14BK Virus Infection Key Products15 BK Virus Infection Unmet Needs16BK Virus Infection Market Drivers and Barriers17BK Virus Infection Future Perspectives and Conclusion18BK Virus Infection Analyst Views19Appendix20About DelveInsight Get customized pipeline report @ BK Virus Infection Drug Treatment Related Reports BK virus (BKV) Infection Market DelveInsight's BK virus (BKV) Infection - Market Insights, Epidemiology, and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology. BK virus (BKV) Infection Epidemiology Forecast DelveInsight's BK virus (BKV) Infection - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of BK virus (BKV) Infection in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Adeno-Associated Virus Vectors in Gene Therapy Market DelveInsight's "Adeno-Associated Virus (AAV) Vectors in Gene Therapy - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology. Chronic Hepatitis B Virus Market DelveInsight's Chronic Hepatitis B Virus- Market Insights, Epidemiology and Market Forecast - 2030 report provides an in-depth understanding of historical and forecasted epidemiology. Chronic Hepatitis Delta Virus (HDV) Infection Market DelveInsight's Chronic Hepatitis Delta Virus (HDV) Infection - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology. Epstein Barr Virus (EBV) Market DelveInsight's Epstein Barr virus (EBV) - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology. About DelveInsightDelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. CONTACT: Contact Us: Shruti Thakur info@delveinsight.com +1(919)321-6187 www.delveinsight.com
A second member of the regulator that oversees Texas' utilities resigned on Monday in a continuation of the political fallout over a weather-driven crisis in the state's power market. Shelly Botkin resigned effective immediately, the Public Utility Commission of Texas said in a one sentence notice. Electricity and natural gas prices surged as an arctic air mass brought subzero temperatures, killing dozens of people and leaving much of its power market in the throes of a deep financial crisis.
His personal wealth soared as the video conferencing platform became a household name during the pandemic.
Leon Gast, the director of the Oscar-winning documentary “When We Were Kings,” about Muhammad Ali’s iconic “Rumble in the Jungle” boxing match, has died. He was 85. Gast died on Monday at his home in Woodstock, NY following a long illness, according to the Woodstock Film Festival, of which Gast was a member of the advisory board. “We are deeply saddened by the passing of Academy Award-winning documentarian Leon Gast,” the festival tweeted. “Leon passed away peacefully this morning at his home. A longtime resident of Woodstock, Leon was one of the festival’s earliest friends and supporters. He will be missed dearly.” Also Read: Mark Wilson, '60s TV Magician Known for 'Magic Land of Allakazam,' Dies at 91 Gast was in Kinshasa, Zaire in 1974 attempting to tell a story about a music festival happening in the country before he turned his attention to the fight in which Ali won back the heavyweight title from George Foreman. He would spend over two decades working to complete the film, pivoting instead to documentaries on The Grateful Dead and the Hell’s Angels in order to get the funding to finish it. Part of the trouble was that he had to comb through a mountain of footage and ultimately got funding from his former lawyer David Sonenberg before finally debuting it at Sundance in 1996. “When We Were Kings” won the Special Jury Prize from the festival and would go on to win the Oscar and an Independent Spirit Award that year and has since been held up as one of the greatest sports documentaries ever made. Some of Leon Gast’s other films include “Smash His Camera,” a film about paparazzi photographer Ron Galella, as well as “Manny” about another boxing icon, Manny Pacquiao, that debuted in 2014. Gast is survived by his wife, Geri. We are deeply saddened by the passing of Academy Award-winning documentarian Leon Gast. Leon passed away peacefully this morning at his home. A longtime resident of Woodstock, Leon was one of the festival's earliest friends and supporters. He will be missed dearly. pic.twitter.com/dNvWRCzM4i — Woodstock Film Festival (@woodstockfilm) March 9, 2021 Read original story Leon Gast, Oscar-Winning Director of Muhammad Ali Doc ‘When We Were Kings,’ Dies at 85 At TheWrap
Mike Foltynewicz is almost as perplexed about how quickly his velocity has returned this spring with the Texas Rangers as the former All-Star was about how quickly it went away last summer when his former team gave up on him. The right-hander peeked at the scoreboard after the first pitch of his spring training debut Monday with Texas and saw 95 mph. He also hit 96-97 mph on other pitches. “Last year, I just literally don’t know what happened,” Foltynewicz said. “I kept throwing and I kept doing everything I needed to do. And I just don’t know what happened. So for all of this to play out right now ... just to see those numbers, yes, it’s very assuring, and that tick of confidence goes up a little bit more.” For both Foltynewicz and the pitching-needy Rangers, who unlike the playoff-bound Atlanta Braves in the shortened season last summer, have some time to find out if the 29-year-old right-hander is getting back to form. Those two perfect innings against the defending World Series champion Los Angeles Dodgers on Sunday in Arizona were an encouraging first step. “That exceeded my expectations,” manager Chris Woodward said. “It meant the world to him to kind of get back out there and, you know, resemble his old self. And it was easy. It wasn’t like he was trying to force it to be 95, 96 (mph). It just was natural. It’s just the way his body was moving, which it had in the past.” Foltynewicz has added back at least 10 pounds to his lanky 6-foot-4 frame, regaining some strength lost during baseball's shutdown because of the pandemic that started in spring training and lasted about four months. In his only start once the season began, he allowed six runs, three homers and four walks in 3 1/3 innings with a flat fastball at around 90 mph. The Braves designated him for assignment after that 14-5 loss to Tampa Bay, sent him to their alternate site when he wasn't claimed off waivers and didn't offer a new contract after the season. While a bit surprised by the move last summer, Foltynewicz said he understood the Braves were trying to win a championship in a short season — they did get to the NL Championship Series played at the Rangers' new ballpark, and he was there without playing. “They gave me plenty of chances in the past,” he said. “It's a business, I get all of that part of it. But in the back of the mind, it kind of fuels you a little bit when someone gives up on you like that.” An All-Star in 2018, when he was 13-10 with a 2.85 ERA in 31 regular-season starts, Foltynewicz was sent back to Triple-A midway through the 2019 season to work out some early-season issues. He finished strong after getting called back up, then pitched seven scoreless innings against St. Louis in Game 2 of the NL Division Series. But he also started the deciding Game 5 when the Cardinals had a 10-run first inning. Foltynewicz signed a $2 million, one-year contract with Texas just before the start of spring training and is not eligible for free agency until after the 2022 season. Even though Foltynewicz was throwing and running every day when players were away from their teams last year, with gyms closed and lacking certain equipment, he wasn't able to maintain his strength by doing squats and other weights workouts. The impact was obvious, though Foltynewicz and the Rangers said explaining his regained velocity now isn't just as simple as regained strength. “There’s so much more than that,” Woodward said. While Foltynewicz made adjustments to his eating habits and lifestyle, there was also the biomechanical and analytical approach Rangers pitching coaches presented to him even before he signed with them. “Basically diagnosing some of the problems or the things that they could help fix, I think that’s what really set maybe us apart from other teams in his mind,” Woodward said. “And you see the impact that it’s had already. His first outing was it was beyond what I even expected. I was expecting it to be decent, but that was pretty dominant.” It was the kind of velocity that made Foltynewicz successful in the past, since all of his other pitches — slider, changeup and curveball — then work off that. After that initial 95 mph pitch which got out Mookie Betts on a flyball, Foltynewicz said he was able to take a deep breath and then attack hitters and use all of his stuff. “You get weak contact, strikeouts, whatever it may be, and you just have fun," he said. ”You start having fun again in the game of baseball." ___ More AP MLB: https://apnews.com/hub/MLB and https://twitter.com/AP_Sports Stephen Hawkins, The Associated Press
Women in Film, Los Angeles (WIF), an advocacy organization for women’s screen careers, has added six members to its 2021 Board of Directors, the organization announced Monday. The new group includes Niija Kuykendall, executive vice president of production at Warner Bros. Pictures; Michelle Lee, director of domestic programming at AppleTV+; film and television producer Monica Levinson (“Borat Subsequent Moviefilm”); producer Chris Nee, whose production company Laughing Wild is focused on nurturing talent with diverse points of view; Shivani Rawat, founder and CEO of ShivHans Pictures; and Ida Ziniti, co-head of the Motion Picture Literary Department at Creative Artists Agency (CAA). In making the announcement, board president Amy Baer, CEO of Gidden Media, said, “Each of these impressive women is uniquely expert, whether as an executive producer, creator, or agent. Their diverse skill sets will help us to continue championing the advancement of women across all facets of the screen industries.” Also Read: Women Directed Record 16% of Top-Grossing 2020 Films, Report Shows In her statement, Baer also thanked outgoing board members Stephanie Allain, Orly Anderson, Adriana Alberghetti, Cheryl Boone Isaacs and Keri Putnam, all of whom have completed their terms. WIF executive director Kirsten Schaffer added, “As we continue to adapt our organization to the changing needs of our community, especially in what has become a ‘new normal’ for life and work during a sustained crisis, we are proud to have a 2021 Board of Directors who are committed to our mission of creating an industry where equity is a priority for success. We are also continuing our commitment to leading by example, with balanced representation of women if color and members of the LGBTQ+ community among our board and staff.” Women in Film, Los Angeles was founded in 1973 to advance careers for women working in the screen industries, providing pipeline programs and advocating for gender parity through research, education and media campaigns. Membership is open to all screen industry professionals. Read original story Women In Film, Los Angeles Adds 6 New Board Members At TheWrap
New York, New York--(Newsfile Corp. - March 8, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Astrazeneca Plc ("Astrazeneca") (NYSE: AZN) between May 21, 2020 and November 20, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Southern District of New York. To get more ...
The Republican Party intends to keep using former President Donald Trump's name in fundraising pitches and other materials, a lawyer for the party said on Monday, despite a cease-and-desist letter from Trump last week. The letter sent by lawyers for Trump on Friday to the Republican National Committee, National Republican Congressional Campaign and National Republican Senate Campaign had ramped up tension between the two camps as Trump seeks to preserve his political viability post-election. A Trump adviser said on Saturday that Trump was sensitive to the use of his name and likeness for branding purposes and was irked the three groups have supported Republican lawmakers who joined Democrats in voting to impeach him over the Jan. 6 storming of the U.S. Capitol by pro-Trump protesters.
Thousands of Paraguayans gathered around Congress in downtown Asunción on Monday, marking the fourth day of protests amid calls to impeach President Mario Abdo over the government's handling of the COVID-19 health crisis. The protesters, many wearing soccer jerseys and carrying national flags, chanted "Out Marito" and "Everyone out", while criticizing the authorities for the lack of medicines and intensive care beds amid a spike in coronavirus cases. "In the hospitals there are no syringes, there are no beds," a young man who identified himself as Dudu Dávalos told local television after traveling from the city of Hernandarias, 340 km (210 miles) east of Asunción.